1 day Ago By Defense World Staff
Norges Bank acquired a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,665 shares of the company’s stock, valued at approximately $619,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Rhumbline Advisers raised its stake in Privia Health Group by 1.3% during the 4th quarter.
Rhumbline Advisers now owns 287,200 shares of the company’s stock worth $5,615,000 after buying an additional 3,658 shares during the period. Nordea Investment Management AB increased its holdings in shares of Privia Health Group by 33.1% during the fourth quarter.
Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after acquiring an additional 86,910 shares in the last quarter. Franklin Resources Inc. raised its position in shares of Privia Health Group by 2.
2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after purchasing an additional 28,480 shares during the period.
Barclays PLC lifted its holdings in shares of Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after purchasing an additional 158,188 shares in the last quarter.
Finally, JPMorgan Chase & Co. grew its position in Privia Health Group by 8.4% in the 3rd quarter.
JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after purchasing an additional 14,641 shares during the period. Institutional investors own 94.
48% of the company’s stock. Privia Health Group Price PerformanceShares of Privia Health Group stock opened at $24.10 on Friday.
The stock has a fifty day moving average price of $23.76 and a 200-day moving average price of $21.49.
The firm has a market cap of $2.92 billion, a PE ratio of 241.02, a P/E/G ratio of 3.
47 and a beta of 0.88. Privia Health Group, Inc.
has a 1 year low of $15.92 and a 1 year high of $26.04.
Analyst Ratings ChangesSeveral research firms have weighed in on PRVA. Truist Financial upped their price objective on shares of Privia Health Group from $27.00 to $28.
00 and gave the stock a “buy” rating in a report on Thursday. Canaccord Genuity Group raised their price target on shares of Privia Health Group from $29.00 to $30.
00 and gave the company a “buy” rating in a research report on Friday, February 28th. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd.
JMP Securities set a $29.00 price objective on Privia Health Group in a research note on Friday, February 28th. Finally, Macquarie started coverage on Privia Health Group in a research report on Monday, December 16th.
They set an “outperform” rating and a $25.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock.
According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $26.87.View Our Latest Analysis on PRVAInsider Buying and SellingIn other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction dated Wednesday, April 2nd.
The shares were sold at an average price of $22.38, for a total value of $125,999.40.
Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. The trade was a 3.
04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.
20% of the stock is currently owned by corporate insiders. Privia Health Group Company Profile (Free Report)Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See AlsoFive stocks we like better than Privia Health GroupDo ETFs Pay Dividends? What You Need to KnowRobinhood Strategies Could Be a Game-Changer for Young InvestorsHow to Calculate Retirement Income: MarketBeat’s CalculatorAre These 3 Retail Stocks Oversold or Really in Trouble?Bank Stocks – Best Bank Stocks to Invest InIONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead.
